Q-Centrix, a portfolio company of Sterling Partners, said Tuesday that it has hired Milton G. Silva-Craig as its new CEO. The appointment is effective immediately. Silva-Craig replaces Rob Schwager, who is transitioning from CEO to chairman. Previously, Silva-Craig worked at TransUnion’s healthcare business unit where he served as president. Based in Portsmouth, N.H., Q-Centrix is an outsourced provider of healthcare solutions.
CHICAGO & PORTSMOUTH, N.H.–(BUSINESS WIRE)–Q-Centrix LLC and its growth partner Sterling Partners announced today the appointment of Milton G. Silva-Craig as Q-Centrix’s new CEO, effective immediately. Silva-Craig will accelerate the growth profile of the company by expanding its client base, offering new services such as concurrent review, infection control and admission surveillance, and introducing and applying new technologies to provide even more in-house efficiencies for healthcare clients.
Dan Hosler, principal at Sterling Partners, said, “In the current healthcare landscape, increasing reporting burdens make it extremely difficult for quality departments to keep pace. We believe that Q-Centrix is the gold standard for quality departments looking to partially or fully outsource the ever-increasing number of quality metrics at a fraction of the cost. We are thrilled to help Q-Centrix continue its growth trajectory as it provides new and innovative services that allow its clients to benefit from the healthcare system’s quality-based reimbursement model.”
Silva-Craig assumes the leadership of Q-Centrix from Rob Schwager, who is transitioning from his role as CEO to Chairman. Schwager, who built Q-Centrix from the ground up and established it as an industry leader in just three years, will continue to provide strategic direction.
“Milton brings the strategic perspective, organizational skills and industry experience that will catapult Q-Centrix to the next level of growth, while still delivering superior levels of accuracy, dependability and cost efficiency to quality departments of acute care hospitals,” said Schwager.
“What Rob has created in such a short period of time with Q-Centrix is remarkable,” said Silva-Craig. “I’ll work closely with Rob during this transition period and leverage his institutional knowledge as we continue to evolve and scale. Exceptional client service and great client retention have become the hallmarks of Q-Centrix. With our intent to add technology and data knowledge to our offerings, I think we are only scratching the surface relative to the innovation we can bring to this industry, healthcare facilities and their patients. I look forward to leading the team and working closely with our nearly 300 hospital clients as we begin our next phase of growth.”
With more than 20 years of experience in the healthcare and information technology industries, Silva-Craig has demonstrated success in leading and managing high-growth businesses. Prior to Q-Centrix, Silva-Craig served as president of TransUnion’s healthcare business unit. There, he developed and executed a strategic business plan focused on growing and repositioning TransUnion in the healthcare marketplace. His work resulted in an eight-fold increase in growth of the business unit. At Emageon Inc. (NASDAQ: EMAG), Silva-Craig led the company’s strategic direction and operations. He grew revenues from several hundred thousand dollars to more than $100 million, and eventually led Emageon through its initial public offering. He was also president and CEO of Technology Solutions Company (NASDAQ: TSCC) and held executive positions at General Electric Medical Systems. Silva-Craig earned a J.D. from the University of Wisconsin School of Law in Madison and obtained his M.B.A. and B.A. from the University of Wisconsin – Madison.
Sterling Partners welcomed Q-Centrix into its portfolio in December 2013. Sterling focuses on partnering with like-minded entrepreneurs and investing growth capital in small- and mid-market companies in industries with positive, long-term trends.
Q-Centrix is the largest exclusive provider of outsourced retrospective and concurrent Core Measure and Registry data abstraction for acute care hospitals. The company uses proprietary technology and a team of outsourced abstractors to collect data for chart-based core measures and registry collection from hospital record systems. With specialization of knowledge and process, Q-Centrix is able to deliver levels of accuracy, dependability and cost efficiency which exceed that of typical in-house abstracting staff. For more information visit: www.Q-Centrix.com.
About Sterling Partners
Sterling Partners is a private equity firm with a distinct point of view on how to build great companies. Founded in 1983, Sterling has invested billions of dollars, guided by the company’s stated purpose: INSPIRED GROWTH™, which describes Sterling’s approach to buying differentiated businesses and growing them in inspired ways. Sterling focuses on investing growth capital in small- and mid-market companies in industries with positive, long-term trends – education, healthcare and business services. Sterling provides valuable support to the management teams of the companies in which the firm invests through a deep and dedicated team of operations and functional experts based in the firm’s offices in Chicago, Baltimore and Miami.
The people at Sterling believe in ideas and ideals, in people and partnerships that drive long-term success. For more information, please visit www.sterlingpartners.com.